v3.26.1
Earnings Per Share
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Earnings Per Share

Note 2 – Earnings Per Share

Basic earnings per share (“EPS”) is calculated by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is calculated by dividing net income by the weighted average number of common shares outstanding for the period adjusted to include the effect of outstanding stock options, if dilutive, using the treasury stock method. Shares issued during any period are weighted for the portion of the period they were outstanding.

Note 2 – Earnings Per Share (concluded)

 

The following schedule presents earnings per share data for the three months ended March 31, 2026 and 2025 (in thousands, except per share data):

 

 

Three months ended March 31,

 

 

 

2026

 

 

2025

 

 

Net income applicable to common stock

 

$

6,229

 

 

$

5,378

 

 

Weighted average number of common shares outstanding

 

 

6,788

 

 

 

6,905

 

 

Basic earnings per share

 

$

0.92

 

 

$

0.78

 

 

Net income applicable to common stock

 

$

6,229

 

 

$

5,378

 

 

Weighted average number of common shares outstanding

 

 

6,788

 

 

 

6,905

 

 

Dilutive effect on common shares outstanding

 

 

20

 

 

 

59

 

 

Weighted average number of diluted common shares
   outstanding

 

 

6,808

 

 

 

6,964

 

 

Diluted earnings per share

 

$

0.91

 

 

$

0.77

 

 

 

Restricted stock units and options to purchase 174,751 shares of common stock at a weighted average exercise price of $30.75 were included in the computation of diluted earnings per share for the three months ended March 31, 2026. There were no antidilutive shares to be excluded from the computation of diluted earnings per share at March 31, 2026.

 

Restricted stock units and options to purchase 260,698 shares of common stock at a weighted average exercise price of $26.99 were included in the computation of diluted earnings per share for the three months ended March 31, 2025. There were no antidilutive shares to be excluded from the computation of diluted earnings per share at March 31, 2025.